CVE-2022-29182

DOM-based XSS in GoCD

Description

GoCD is a continuous delivery server. GoCD versions 19.11.0 through 21.4.0 (inclusive) are vulnerable to a Document Object Model (DOM)-based cross-site scripting attack via a pipeline run's Stage Details > Graphs tab. It is possible for a malicious script on a attacker-hosted site to execute script that will run within the user's browser context and GoCD session via abuse of a messaging channel used for communication between with the parent page and the stage details graph's iframe. This could allow an attacker to steal a GoCD user's session cookies and/or execute malicious code in the user's context. This issue is fixed in GoCD 22.1.0. There are currently no known workarounds.

Category

4.3
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.91% Top 30%
Vendor Advisory gocd.org
Affected: gocd gocd
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2022-29182?
CVE-2022-29182 has been scored as a medium severity vulnerability.
How to fix CVE-2022-29182?
To fix CVE-2022-29182, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-29182 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-29182 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-29182?
CVE-2022-29182 affects gocd gocd.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.